Alfie Milne Young Investigator Award

The Alfie Milne Young Investigator Award is a one-year grant designed to support early career researchers, such as postdoctoral and clinical fellows or instructors, pursuing promising research ideas related to complex lymphatic anomalies including Gorham Stout Disease (GSD), Generalized Lymphatic Anomaly (GLA), Kaposiform Lymphangiomatosis (KLA) and Central Conducting Lymphatic Anomaly (CCLA). This grant aims to cultivate the best and brightest researchers of the future who demonstrate a commitment to a career in lymphatic research. This is a mentored award, and the research project is conducted under the guidance of a scientific mentor. U.S. and international researchers with a focus on complex lymphatic anomalies can apply.

Alfie Milne Young Investigator Award is a one-year grant totaling $25,000 that supports personnel and/or direct research expenses. This award is made possible by a charitable donation from Lymphangiomatosis & Gorham’s Disease Alliance, United Kingdom (LGDA UK).

Eligibility Criteria – Please note the updated eligibility requirements.
This RFA is open globally. International applicants are invited to apply. Graduate and medical students actively doing research are eligible for the award. Additionally, individuals with a PhD, MD, or MD/PhD who do not have an appointment higher than Instructor are eligible to apply.

How to Apply
Submit a LOI to the LMI. If your LOI is selected, you will be invited to submit a full grant application.

Letter of Interest Instructions
The completed one-page LOI is to be emailed to grants@lmiresearch.org and due no later than Friday, May 24, 2024 by 11:59pm (EST).

Full Applications
Invitation only. Full applications due Friday, July 26, 2024 no later than 11:59pm (EST) and emailed to grants@lmiresearch.org.

Documents
See below for the links to download instructions and form templates for the Alfie Milne Young Investigator application.

Grant Review Process

Grants will be reviewed for scientific content and relevance to the goals of the RFA.
Full applications proceed through a two-step review process. The first step includes external review and rating with an assessment of the strengths and weaknesses of each application based on the defined review criteria described below. During the second step, funding recommendations are determined based on an assessment of the reviewer scores and written comments. Final decision of funding will be made by leadership of LMI, LGDA, and LGD Alliance Europe.

Anonymous reviewer feedback is shared with the applicant.

Confidentiality
The LMI Programs are a confidential process and all content of the LOIs and Full Applications will be kept confidential. In order to encourage sharing of new techniques and findings to advance science, after funding decisions are made, the LMI will share a non-confidential lay summary of the research proposals received (required with your letter of intent), including those that were not funded, with LGDA and LGDA Europe (funding organizations). The LMI aims to respect and protect the integrity of your work, and thus will not release any proprietary information.